Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment (Q39479158)

12 September 2017

title

Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment (English)

1 reference

12 September 2017

1 reference

Brant Pohorelic

1

1 reference

12 September 2017

R Singh

2

1 reference

12 September 2017

S Parkin

3

1 reference

12 September 2017

K Koro

4

1 reference

12 September 2017

A-D Yang

5

1 reference

12 September 2017

C Egan

6

1 reference

12 September 2017

A Magliocco

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

6 September 2011

1 reference

Breast Cancer Research and Treatment

12 September 2017

published in

1 reference

12 September 2017

volume

133

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

201-214

1 reference

The clinical course of bone metastases from breast cancer

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Clinical course and prognostic factors following bone recurrence from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Metastasis: the seed and soil theory gains identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Evaluating distant metastases in breast cancer: from biology to outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Combined transcriptome and genome analysis of single micrometastatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Review: Biological relevance of disseminated tumor cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Bone targeted therapy in breast cancer: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Emerging therapeutic targets in breast cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

The role of Src in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Src kinases as therapeutic targets for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

SRC as a therapeutic target in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Expanding the role of Src and protein-tyrosine phosphatases balance in modulating osteoblast metabolism: lessons from mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Src kinase activity is essential for osteoclast function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Latent bone metastasis in breast cancer tied to Src-dependent survival signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Breast cancer SRC activity: bad to the bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

SRC kinase inhibition: targeting bone metastases and tumor growth in prostate and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Clinical development of SRC tyrosine kinase inhibitors in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Altered tyrosine 527 phosphorylation and mitotic activation of p60c-src

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Selected glimpses into the activation and function of Src kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Activation of human pp60c-src

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

pp60c-src activation in human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

The when and how of Src regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Structure-function relationships in Src family and related protein tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Src phosphorylates Grb2-associated binder 1 upon hepatocyte growth factor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Hepatocyte Growth Factor/scatter factor-induces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Src kinase contributes to the metastatic spread of carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Is Src a viable target for treating solid tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Chemokine CCL2 facilitates ICAM-1-mediated interactions of cancer cells and lymphatic endothelial cells in sentinel lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

c-Src/Histone Deacetylase 3 Interaction Is Crucial for Hepatocyte Growth Factor Dependent Decrease of CXCR4 Expression in Highly Invasive Breast Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1753-2

10.1007/S10549-011-1753-2

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference